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Central Asia is a vast geographic region that includes five former Soviet Union republics: 
Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan. The region has a 
unique infectious disease burden, and a history that includes Silk Road trade routes and 
networks that were part of the anti-plague and biowarfare programs in the former Soviet 
Union. Post-Soviet Union biosurveillance research in this unique area of the world has 
met with several challenges, including lack of funding and resources to independently 
conduct hypothesis driven, peer-review quality research. Strides have been made, how-
ever, to increase scientific engagement and capability. Kazakhstan and Kyrgyzstan are 
examples of countries where biosurveillance research has been successfully conducted, 
particularly with respect to especially dangerous pathogens. In this review, we describe 
in detail the successes, challenges, and opportunities of conducting biosurveillance in 
Central Asia as exemplified by our recent research activities on ticks and tick-borne 
diseases in Kazakhstan and Kyrgyzstan.
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BACKGROUnD
Biosurveillance research and environmental monitoring have been conducted in Central Asia since 
the Russian anti-plague (AP) network in the 1890s set up by Czar Nicholas II (1). This network was 
originally organized geographically, to conduct surveillance of local diseases, such as plague, and to 
prevent introduction of diseases with no natural foci, such as cholera (2). During the Soviet era, the 
AP network evolved into a highly structured organization that included over 100 facilities: observa-
tional, field, regional stations, and institutes, across the 11 republics that were administered by the 
Union of Soviet Socialist Republics’ Ministry of Health (3). After the Soviet Union collapsed, each 
country maintained its own AP system that varies by country (4). All have experienced challenges 
of limited funding and lack of training for their specialists, while competition for limited funds 
FiGURe 1 | Commonwealth of independent states – Central Asian States. Reproduced with permission from (6).
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has decreased collaboration as well as development of programs 
fostering peer-reviewed quality research and related funding.
Two countries that exemplify the current status of biosurveil-
lance in Central Asia are Kazakhstan and Kyrgyzstan. Kazakhstan 
(2.7 million square kilometer; 18 million people) has national 
wealth in the forms of oil, natural gas, and mineral resources1 
but still relies heavily on imported expertise and technology 
to further develop their resources (5). Kyrgyzstan (0.2 million 
square kilometer; 5.7 million people) has no oil or natural gas 
but has mineral resources (see text footnote 1), and also relies on 
imported expertise and technology (6) (Figure  1). In addition 
to commercial ventures with foreign petroleum companies, aid 
to both countries has come from the United States Department 
of Defense (US DoD) cooperative threat reduction (CTR) 
program, through the 1991 Soviet Nuclear Threat Reduction 
1 https://www.cia.gov/library/publications/the-world-factbook/geos/kg.html
Initiative. The governments of both countries are cooperating on 
biological threat reduction efforts, with an emphasis on disease 
surveillance, biosafety, and biosecurity. As with other supporting 
nations, aid from the United States (US) first requires a formal 
government-to-government (umbrella) agreement, which estab-
lishes diplomatic intent and cooperation. Next, an implementing 
agreement is established with a specific US government agency. 
In Kazakhstan, an umbrella agreement was signed in December 
1993 and the implementing agreement was signed in 1995. The 
cooperation includes a broad range of nuclear security and 
non-proliferation topics. Kyrgyzstan has also signed bilateral 
investment and trade agreements with the US. In Kyrgyzstan, 
multiple foreign agencies have been involved in projects utilizing 
the country’s AP system and run through the Republic Center 
of Quarantine and Especially Dangerous Infections (RCQEDI) 
(4). For example, International Science and Technology Center 
(ISTC), Civilian Research and Development Foundation (CRDF) 
Global, United States Department of State (US DoS), and the 
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United Kingdom Ministry of Defense (UK MoD) have all set up 
collaborative biosurveillance projects with local scientists.
Historically, tick-borne diseases have been important public 
health issue in Central Asia, and biosurveillance has involved 
regular collection and archiving of tick samples. Collection local-
ity information associated with these samples has already con-
tributed to vector biogeography databases, such as VectorMap.2 
Analyses of these frozen tick samples (e.g., molecular testing for 
evidence of infection by pathogens) offer numerous opportuni-
ties for additional research and collaboration, some examples of 
which are described below. In a recent paper, Han et al. (7) pre-
dicted the existence of a large reservoir of undiscovered zoonotic 
infections in this part of the world.
As examples of the accomplishments and challenges of 
biosurveillance research conducted in Central Asia we present 
below, as case studies, our work on ticks and tick-borne diseases 
conducted in Kazakhstan and Kyrgyzstan over the past decade. 
This work includes studies of tick-borne encephalitis (TBE) in 
both counties and of rickettsial diseases, Q fever, Crimean Congo 
hemorrhagic fever (CCHF), and hemorrhagic fever with renal 
syndrome (Hantaviruses) in Kazakhstan. For reasons of space 
limitation, we will not discuss the CCHF (8) or Hantavirus work 
in Kazakhstan (9) here.
TiCK-BORne enCePHALiTiS
Tick-borne encephalitis is caused by a flavivirus (TBEV); there 
are three types: European, Siberian, and Far-Eastern. Of these, 
the Far-Eastern strain causes the most serious disease. Infection 
is spread to humans through tick bites and through ingestion of 
raw milk and milk products (10). Wild and domestic animals may 
be hosts for the virus (10). TBE is endemic in a wide range of 
European and Asian countries, and effective vaccines are avail-
able in many countries (11). Anecdotal information and papers 
in the local literature suggested that the virus and the disease may 
be more widespread than was understood, in particular, that the 
virus may range in more southerly locations in Asia (11, 12).
Based on this, we initiated a series of studies in Kyrgyzstan. We 
found TBEV in the taiga tick (Ixodes persulcatus) and in rodents 
including the Himalayan field mouse (Apodemus pallipes), a 
previously unknown TBEV host (13). Sequencing studies showed 
this Kyrgyz virus to be a close relative of a Siberian strain from 
Novosibirsk (13). We also identified the virus in a sample from 
a fatal case of TBEV involving a hiker who had visited an area 
where we found the virus in ticks (13). Thus, TBEV and TBE 
appear to occur much further south (42.6°N) and at much higher 
altitudes (~2,100 m) than previously believed (13).
Following this, we extended our TBE/TBEV research into 
Kazakhstan to identify and characterize TBEV there. This work, 
part of collaboration with Kazakhstani colleagues from three 
government agencies, has yielded several interesting findings 
over the past decade. Using modern molecular methods and an 
epidemiologically based approach, we tested human and animal 
samples from selected areas where TBE is known or suspected 
2 http://www.vectormap.org/dataportal.htm
to occur and found strong evidence that TBEV does circulate 
in Kazakhstan Scientific colleagues from the Kazakh Scientific 
Center of Quarantine and Zoonotic Diseases (KSCQZD), 
Scientific Practical Center for Sanitary Epidemiological 
Expertise and Monitoring (SPCSEEM), and Uralsk Anti-Plague 
Station (UAPS) collaborated to provide samples and associated 
collection data, and assist with diagnostics. UAPS staff focused 
its work on tick samples from West Kazakhstan and Aktobe 
oblasts; KSCQZD staff collected ticks from Almaty, Kostanay, 
Kyzylorda, Mangystau, South Kazakhstan, and Zhambyl oblasts; 
and SPCSEEM staff obtained ticks from Atyrau, East Kazakhstan, 
Karaganda, North Kazakhstan, and Pavlodar oblasts. Collectively, 
tick samples included over 40,000 specimens collected from 13 of 
Kazakhstan’s 14 oblasts (i.e., provinces). Samples from captured 
rodents and stored human sera were shared by staff of UAPS and 
SPCSEEM, respectively. Our US-based staff provided technical 
guidance to Kazakh to facilitate confirmation of morphological 
tick identification by molecular methods [e.g., polymerase chain 
reaction (PCR) and pooling and testing of ticks for infection by 
TBEV, CCHFV, and Rickettsia spp. by enzyme-linked immuno-
sorbent assay (ELISA) and quantitative real-time PCR (qPCR)].
As we hypothesized, TBEV is more widespread in Kazakhstan 
than was previously believed. Areas in the southern and eastern 
regions harbor infected ticks (14). Unfortunately, we were unable 
to get material from the western region, where we have strong sus-
picions that the virus also circulates. In the southern and eastern 
regions, data from 2005 to 2014 show, on average, 35 cases or 0.22 
cases per 100,000 per year (15). This burden of disease apparently 
occurs in spite of the fact that up to 50,000 doses of vaccine are 
administered in endemic areas each year. Additionally, we found 
evidence of TBEV infection in ticks in the genera of Dermacentor, 
Hyalomma, and Haemaphysalis (14, 16, 17). The collective range 
of these ticks is much broader than that of I. persulcatus, suggest-
ing that residents of a much broader area of Kazakhstan may be at 
risk for exposure to the virus (14). We are currently investigating 
the role of raw milk and cheese in the spread of TBE.
In summary, we have substantial new data on a serious 
tick-borne disease in Central Asia, of importance both to local 
and global public health authorities, as well as the US DoD. 
Acknowledging these successes, and the essential collaboration 
of the Kazakhstani and Kyrgyz authorities and our scientific col-
leagues, there are nevertheless issues that impede further devel-
opment of our novel findings; these issues are discussed in the 
Section “Conclusion: Accomplishments and Challenges” below.
RiCKeTTSiAL DiSeASeS
Historically, tick-borne rickettsial diseases in Kazakhstan were 
attributed solely to Siberian tick typhus. Siberian tick typhus 
is caused by Rickettsia sibirica subsp. sibirica that is trans-
mitted by ixodid ticks (i.e., Dermacentor and Haemaphysalis 
spp.) (18). Between 2007 and 2012, 1,247 registered cases of 
Siberian tick typhus were recorded in Kazakhstan, with the 
highest prevalence (65%) occurring Kyzylorda and North 
Kazakhstan Oblasts (17). Whether these cases were truly due 
to Siberian tick typhus and/or other rickettsioses was not clear, 
because serological assays are cross-reactive for antibodies 
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against the spotted fever group rickettsiae (SFGR) (19). Indeed, 
recent tick surveys have identified four additional SFGR species 
that may be responsible for rickettsial diseases in Kazakhstan 
(18, 20–22). These four agents, Rickettsia conorii subsp. caspia, 
Rickettsia slovaca, Rickettsia raoultii, and a Rickettsia aeschli-
mannii-like organism, were identified in collaborative studies 
between Russian and Kazakhstani scientists (18, 20–22).
Additional studies performed in Kazakhstan confirmed the 
presence of tick-borne rickettsiae among ticks collected through 
tick drags and small mammal trapping. During the spring of 
2004, a study conducted by the UAPS in the southern tip of West 
Kazakhstan Oblast collected 33 Rhipicephalus pumilio ticks. 
Two ticks (6%) were positive for rickettsial DNA and data from 
subsequent sequencing analyses identified the agents as R. conorii 
subsp. caspia, the causative agent of Astrakhan spotted fever 
(17). Assessment of 330 ticks collected by tick drag in Karaganda 
Oblast in Central Kazakhstan by SPCSEEM determined that they 
were all D. marginatus. Of the 33 pools of these ticks tested for 
infection by rickettsial pathogens (10 ticks per pool), 2 from the 
Abai Rayon were positive (17).
Most recently (2012–2014), one large tick surveillance study 
supported by US Defense Threat Reduction Agency (DTRA) was 
conducted in Kazakhstan. One aspect of the investigation focused 
on detecting tick-borne rickettsiae and involved ticks collected 
in seven oblasts: Atyrau, East Kazakhstan, Zhambyl, Karaganda, 
Kyzylorda, Pavlodar, and West Kazakhstan involving SPCSEEM 
staff in Almaty (17) and UAPS staff in Uralsk (17, 23). The project 
explored both the identification of tick species and the detection 
of Rickettsia positive ticks by qPCR and multilocus sequencing 
typing (MLST); data analysis is ongoing.
Q FeveR
Q fever is caused by the Gram-negative bacterium, Coxiella bur-
netii, and is found all over the world (24). More than 40 species 
of ticks are known to be naturally infected with C. burnetii, and 
though tick-to-human transmission does occur it is only thought 
to be responsible for a small subset of infections (25). The most 
common route of human infection is through the inhalation of 
aerosolized particles, generally the result of the aerosolization of 
dried parturition materials from infected animals (26). Infected 
animals also shed C. burnetii in urine, feces, and milk, the last of 
which may cause infection when consumed without pasteuriza-
tion (25). Q fever has been reported in Kazakhstan since the early 
1950s (27). Currently, UAPS is conducting a study supported by 
DTRA assessing the presence of C. burnetii in unpasteurized milk 
in the West Kazakhstan Oblast utilizing a qPCR assay targeting 
IS1111 DNA (28).
COnCLUSiOn: ACCOMPLiSHMenTS AnD 
CHALLenGeS
Accomplishments
During the last decade in Kazakhstan and Kyrgyzstan, we 
have carried out extensive training and research work in col-
laboration with our local colleagues. These efforts have led 
to enhanced biosafety and biosecurity practices, successful 
implementation of field and laboratory techniques, and aware-
ness and compliance with regulatory standards. Modern rodent 
capture methods were also introduced, which included training 
on the use of live capture traps and safe rodent handling. As 
a result, we have been able to develop technical presentations 
in a number of research areas, many of which are cited in the 
reference list.
Our collaborative studies have also generated extensive col-
lections of field samples and associated analytical datasets. For 
example, we now have over 40,000 ectoparasites from tick drags 
and vertebrate hosts, many of which have been identified both 
by morphological and molecular means. Data, including tick 
species, location (GPS coordinates), and date of collection were 
recorded and shared via public databases.
In the laboratory, enhanced sample processing and use of 
molecular diagnostics were emphasized. Safe and proper proce-
dures for bead-beating tick samples were employed, and nucleic 
acid extraction (DNA and RNA) was performed on those samples 
before qPCR determination of bacterial and viral identity. We 
also demonstrated and implemented methods that comply with 
Federal Wide Registration (FWA) standards for testing of stored 
human sera.
Finally, between 2011 and 2014, our work in central Asia 
produced 20 scientific papers presented at 11 professional con-
ferences. These presentations were developed in collaboration 
with our in-country colleagues. In addition, one peer-reviewed 
manuscript based on this work has been published to date (8).
Overall, these considerable accomplishments have resulted in 
a better trained and aware scientific workforce in Kazakhstan and 
Kyrgyzstan. Our central Asian colleagues have been exposed to 
modern scientific methodology and perspectives and have been 
able to present their work in several major international forums. 
This has led to significant findings in public health in this part of 
Central Asia, which will increase awareness of important infec-
tions locally and globally. Finally, this work will provide a solid 
basis for future planning for infectious disease surveillance and 
research in Central Asia.
Challenges
In the course of all the successful work described above, we 
encountered a number of challenges that are being addressed 
to facilitate continued progress in Kazakhstan and Kyrgyzstan. 
From the literature, one can see that only a few surveyed loca-
tions in this region are reported in peer-reviewed international 
journals. Even from the last large study that surveyed many 
oblasts, the number of rayons (i.e., county or district) studied 
within each oblast was limited, and thus the overall investigation 
is constrained. An obvious solution would be to continue and 
expand biosurveillance studies, varying the sites over time, but is 
time consuming and expensive.
Another issue is the limited submission of research results 
to peer-review, high impact international journals, especially 
English language journals, by local scientists. Scientists around 
the world are developing the scientific credentials through suc-
cessful submission of their results to peer-review journals. This 
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submission process needs to be encouraged for scientists in 
Central Asia, especially in regards to writing detailed results and 
statistics required for publication in peer-reviewed, international 
journals. In addition, the development of this writing skill and 
the publication of notable results will enhance the success at 
developing and submitting proposals for local and international 
grant funding.
A further crucial area for improvement is the development of 
technical skills for assessing and developing assays and methods, 
as well as data analysis. Lack of standard operating procedures 
in Russian, Kazakh, and Kyrgyz languages, and trained technical 
personnel are other problems. Current reliance on commercial 
test assays is costly and unsustainable. Possible solutions to these 
problems include developing reagent/equipment procurement 
streams via known in-country and/or regional commercial enti-
ties and developing in-house assays that can be compared with 
currently accepted commercial assays. Increasing molecular 
diagnostics capabilities at institutions, including government, 
university, and commercial entities, would also be useful, 
particularly if these could be shared with among institutions. 
Limited submission of samples for analysis and verification to 
outside institutions lessens future progress. This issue can only 
be solved by allowing scientists to bring or send test sample 
material to foreign institution; this will not be simple to resolve 
and will require substantial political will on the part of the local 
authorities.
Finally, there are many communication barriers to overcome. 
This would be helped by including each level of work group 
(including technicians, scientists, managers, and directors) in 
discussions of research activity, as well as encouraging clear 
communication within organizations to improve research and 
planning. In our work, we found that direct communication, 
especially face-to-face meetings and conference calls, was most 
effective and decreased the need for written correspondence that 
required language translation.
Overall, the accomplishments in the biosurveillance studies 
conducted in Kazakhstan and Kyrgyzstan presented here dem-
onstrates that significant work can be achieved despite existing 
challenges. With time and continued collaborative efforts, we 
believe that these challenges will overcome, leading to even more 
progress in the future. Current interest in global health security 
activities coupled with the historic zoonotic diseases in this part 
of the world provides ample opportunities for further studies.
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